ask="60.00"
ask_size="100"
average_daily_volume="392118"
bid="N/A"
bid_size="N/A"
book_value="14.23"
change="+0.79"
change_from_200_day_moving_average="-9.00"
change_from_50_day_moving_average="-4.21"
change_from_52_week_high="-20.43"
change_From_52_week_low="9.36"
change_in_percent="+1.99%"
close="40.55"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.44"
ebitda="-97.47M"
eps_estimate_current_year="-4.38"
eps_estimate_next_quarter="-1.15"
eps_estimate_next_year="-2.44"
ex_dividend_date="N/A"
float_shares="24639000"
high="40.87"
high_52_weeks="60.98"
last_trade_date="3/15/2017"
last_trade_price="40.55"
last_trade_size="18656"
last_trade_time="4:00pm"
low="39.68"
low_52_weeks="31.19"
market_capitalization="1.12B"
moving_average_200_day="49.55"
moving_average_50_day="44.76"
name="Five Prime Therapeutics
Inc."
notes="N/A"
one_year_target_price="65.29"
open="39.87"
pe_ratio="N/A"
peg_ratio="0.16"
percent_change_from_200_day_moving_average="-18.17%"
percent_change_from_50_day_moving_average="-9.41%"
percent_change_from_52_week_high="-33.50%"
percent_change_from_52_week_low="+30.01%"
previous_close="39.76"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.79"
price_per_sales="35.64"
revenue="30.69M"
shares_outstanding="27509000"
short_ratio="9.22"
stock_exchange="NMS"
symbol="FPRX"
volume="352017"
weeks_range_52="31.19 - 60.98"
